4/17/2014 - 9:52 AM EST - IMRIS Inc. : announced that a study published this month in the journal Neurosurgery by the neurosurgical team at Cleveland Clinic adds to growing clinical evidence which validates use of high-field intraoperative MRI (iMRI) as an effective tool for maximizing the amount of surgical resection of gliomas (brain tumours). IMRIS Inc.
shares T.IM are trading unchanged at $1.45.
